More
    Guided Solutions - Connecting Talent With Innovation/div>

    Clinical Trials

    Vesalio Secures Class A Funding

    Vesalio announces it has successfully secured a Class A financing round. The proceeds will be utilized to support the ongoing US IDE stroke study,...

    Simple medical device improves care after kidney transplantation

    - Clinical trial shows patients prescribed the geko™ device experienced shortened hospital stays by more than one day after a kidney transplant - The device reduced surgical...

    First Patient Treated in Landmark U.S. Randomized Clinical Trial of NeuraLace’s Chronic Pain Treatment

    Study to Evaluate the Efficacy and Economic Benefit of Axon Therapy® Designed to Relieve Pain and Improve Quality of Life Compared with Conventional Medical...

    Bivacor lands $22M to begin human trials of its magnetic artificial heart

    On a scale of cardiac density that begins with Blondie’s heart of glass and ends with the Rolling Stones’ heart of stone, Houston-based startup Bivacor’s...

    ReCor Medical has positive renal denervation study news

    ReCor Medical‘s renal denervation significantly reduced blood pressure among people with drug-resistant hypertension, according to a new study reported at the American College of...

    Brave new world: trialling VR to ease pain and stress

    Virtual reality has shown the potential to help patients deal with pain and anxiety during difficult procedures and clinical trials. Clinical Trials Arena speaks...

    FDA Grants RenovaCare Full IDE Approval for Safety and Feasibility Clinical Trial

    RenovaCare, Inc., announced that its Investigational Device Exemption (IDE) application has been granted full approval by the U.S. Food and Drug Administration (FDA). This...

    NanoVibronix Announces Start of Real World Patient Study of UroShield

    NanoVibronix, Inc., a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that...

    Innocoll Biotherapeutics initiates Phase 3 trials for collagen drug-device

    Innocoll Biotherapeutics announced that it initiated two Phase 3 trials to support a label expansion for its collagen drug-device implant. Athlone, Ireland-based Innocoll’s trials are seeking...
    1...404142...47Page 41 of 47

    Latest articles

    Popular articles

    Featured

    Newsletter

    [hubspot type=form portal=25601863 id=e07d0241-001f-4840-8c08-6e5a4f7af710]

    © Copyright - Guided Solutions - Global Executive Search in Medical Devices